Paula Schaap

As assistant managing editor, markets, Paula Schaap leads The Deal's coverage of activist investor campaigns and the equity and debt markets, as well as hedge fund and private equity news.

Prior to joining The Deal, Paula was editor of HedgeFund.net and a reporter in the New York office of London-based Financial News, now a division of Dow Jones.

Paula also worked as an editor for American Lawyer Media after leaving a business litigation practice in New York to become a journalist.

Recent Articles By The Author

Windstream Tax Tactic Lifts Telecommmunications Sector

Windstream Tax Tactic Lifts Telecommmunications Sector

After rural landline telephone company Windstream said it had gotten the go-ahead to spin off its fiber and copper networks into a REIT, its stock soared 23%.

Reynolds American, Lorillard Seal Tobacco Merger With UK Assist

Reynolds American, Lorillard Seal Tobacco Merger With UK Assist

Reynolds American and Lorillard are smoking up a merger that, with debt, is valued at $24.7 billion.

Private Equity Karma Might Not Be Right For a Lululemon Sale

Private Equity Karma Might Not Be Right For a Lululemon Sale

After Lululemon Athletica founder Chip Wilson was said to have hired Goldman Sachs to advise him, rumors flew that the yoga apparel maker might be up for sale.

AT&T Pays $67B for DIRECTV as Cable Consolidation Continues Apace

AT&T Pays $67B for DIRECTV as Cable Consolidation Continues Apace

The latest deal in cable: AT&T paying $67 billion, including debt, for DirecTV, is being billed as a way to remake the delivery of video entertainment to customers.

Bill Ackman Goes Corporate Raider Route Backing Valeant in Allergan Bid

Bill Ackman Goes Corporate Raider Route Backing Valeant in Allergan Bid

With Bill Ackman backing Valeant Pharmaceuticals $45 billion hostile takeover attempt for Botox maker Allergan, it appears as though activism has entered a new phase.

Forest Labs, Ashland Roll Up Big Post-Holiday Deals

Forest Labs, Ashland Roll Up Big Post-Holiday Deals

Companies also went shopping on the Presidents Day holiday weekend as Actavis bought Forest Laboratories for $25 billion and Ashland sold its water treatment unit for $1.8 billion. Carl Icahn must be especially happy with the Forest Labs sale as he tried not, once, but twice to get the company to sell itself and still owns a stake in the biotech. It also augurs well for Wall Street advisers who have been waiting for a recovering economy to support an uptick in mergers and acquisitions.

Violin Memory Changes Its Tune

Violin Memory Changes Its Tune

Investment bankers figuring out how much to price an initial public offering at usually try to do right by their client, both on the upside and on the potential downside.

Party City Celebrates IPO Filing

Party City Celebrates IPO Filing

Private equity firm Thomas H. Lee Partners readies Party City for its market debut, but with a heavy debt load, what kind of party will it be?

Deal Economy: Jim Cramer's Takeover Targets for 2014

Deal Economy: Jim Cramer's Takeover Targets for 2014

TheStreet's Jim Cramer gave his predictions for companies that might be likely takeover targets in 2014 at The Deal Economy in New York Thursday.

Deal Economy: Wall Street Looks Forward to Banner Year for M&A

Deal Economy: Wall Street Looks Forward to Banner Year for M&A

Wall Street dealmakers say that conditions are ripe for a take-off in M&A for 2014.